The Barbara Ann Karmanos Cancer Institute, a leading breast cancer prevention and care provider, has adopted Volpara® Risk Pathways™, a market-le...
Samsung Ventures makes investment in Araris Proceeds will be used to support further development and advancement of Araris’ antibody-drug conjugat...
Proceeds from the fund's investment will support Diamond's collaboration with UAB on an investigator-led clinical trial of low-dose psilocybin to treat dem...
The loan carries 10% simple interest, may be prepaid without penalty, is extendable for an additional six months and includes warrants to purchase 390,000 ...
The oversubscribed financing was led by Novalis LifeSciences, with participation from Sozo Ventures, Hatteras Venture Partners, iSelect Fund, American Canc...
The funds will be mainly used to develop lead program Levodopa Cyclops™ for US and EEA marketing, of which early clinical studies already demonstrate...
The proceeds will be deployed to enable Unibio's vision of feeding the world's growing population in a sustainable way. Unibio will use the funds to roll-o...
The proceeds from this Series A extension round are being utilized to advance the development of Trobix Bio's products and cutting-edge proprietary platfor...
The EIC investment was made through its Accelerator Fund, designed to support small and medium enterprises (SMEs), in particular start-ups and spin-out com...
-Labviva, the AI-driven life sciences digital marketplace that simplifies and scales purchasing processes, announced today that it has secured $20 million ...
AnPac Bio-Medical Science Co., Ltd. (Nasdaq: ANPC) ("AnPac Bio," the "Company" or "we"), a company with operations in the United States and ...
SO WHAT: If you purchased Progyny securities you may be entitled to compensation without payment of any out of pocket fees or costs through a continge...
© 2025 Biopharma Boardroom. All Rights Reserved.
